Key result
Pitavastatin attenuates hypertension and albuminuria in hypertensive rats while increasing renal eNOS activity.
Why the study?
The precise mechanism underlying the renoprotective effects of pitavastatin is not fully clarified, particularly its impact on the nitric oxide system.
Does pitavastatin attenuate hypertension and albuminuria in spontaneously hypertensive rats?
RCT
randomized
Does pitavastatin attenuate hypertension and albuminuria in spontaneously hypertensive rats?
Pitavastatin exerts antihypertensive and renoprotective effects in spontaneously hypertensive rats, likely mediated by upregulation of the renal nitric oxide system.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in hypertensive rat models; human trials needed before any clinical consideration.
BACKGROUND: Clinical trials show potent renoprotective effects of pitavastatin (PTV), although the precise mechanism for these renoprotective effects is not fully clarified. The aim of this study was to examine the antihypertensive and renoprotective effects of PTV, focusing on the nitric oxide (NO) system. METHODS: Male, 6-week-old, spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) were randomized to receive vehicle or PTV (2 mg/kg bodyweight) for 8 weeks. Blood pressure and urinary albumin excretion were measured every 2 weeks. After 8 weeks, plasma biochemical parameters and renal histology were examined. NO synthase isoform (neuronal, nNOS; inducible, iNOS; and endothelial, eNOS) expression and eNOS phosphorylation were examined by western blotting. RESULTS: PTV attenuated hypertension and albuminuria development in SHR. PTV decreased glomerular desmin expression and medullary interstitial fibrosis in SHR. PTV tended to increase plasma NO in both strains but significantly increased urinary NO excretion only in WKY. PTV significantly increased nNOS and eNOS expression, enhanced eNOS phosphorylation at serine1177, and inhibited eNOS phosphorylation at threonine495 in the kidney of both strains. CONCLUSIONS: PTV treatment led to increased renal NOS expression and upregulated eNOS activity in both SHR and WKY. The antihypertensive and renoprotective effects of PTV may be related to upregulation of the NO system.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2018) conducted an RCT in hypertension. pitavastatin vs. vehicle was evaluated on Blood pressure and urinary albumin excretion. Pitavastatin attenuated hypertension and albuminuria in spontaneously hypertensive rats and increased renal NOS expression and eNOS activity in both SHR and WKY strains.
Synapse has enriched 10 related papers. Consider them for comparative context: